Stockscreener 앱 받기
13.31
0.23%
0.0271
전일 마감가:
$13.28
열려 있는:
$13.1
하루 거래량:
450.74K
Relative Volume:
0.22
시가총액:
$2.05B
수익:
$276.98M
순이익/손실:
$-59.46M
주가수익비율:
-33.38
EPS:
-0.3987
순현금흐름:
$-48.95M
1주 성능:
+6.91%
1개월 성능:
-17.07%
6개월 성능:
-0.37%
1년 성능:
+76.06%
1일 변동 폭
$12.97
$13.42
1주일 범위
$12.69
$13.88
52주 변동 폭
$6.675
$20.76
Adaptive Biotechnologies Corp Stock (ADPT) Company Profile
명칭
Adaptive Biotechnologies Corp
전화
206-659-0067
주소
1165 EASTLAKE AVE E, SEATTLE, WA
Compare ADPT vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ADPT
Adaptive Biotechnologies Corp
|
13.29 | 2.04B | 276.98M | -59.46M | -48.95M | -0.3987 |
|
VRTX
Vertex Pharmaceuticals Inc
|
450.36 | 114.72B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
732.91 | 78.67B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
680.20 | 42.38B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
312.00 | 41.75B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
281.47 | 31.33B | 5.36B | 287.73M | 924.18M | 2.5229 |
Adaptive Biotechnologies Corp Stock (ADPT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-02 | 재개 | Morgan Stanley | Equal-Weight |
| 2025-09-30 | 개시 | Guggenheim | Buy |
| 2025-06-18 | 개시 | Craig Hallum | Buy |
| 2025-03-21 | 업그레이드 | Goldman | Neutral → Buy |
| 2023-07-05 | 재개 | JP Morgan | Overweight |
| 2023-01-05 | 개시 | Scotiabank | Sector Outperform |
| 2022-12-21 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2022-08-25 | 개시 | Credit Suisse | Underperform |
| 2022-06-03 | 개시 | Piper Sandler | Neutral |
| 2022-02-16 | 재확인 | BTIG Research | Buy |
| 2022-02-16 | 재확인 | BofA Securities | Buy |
| 2022-02-16 | 재확인 | Goldman | Neutral |
| 2022-02-16 | 재확인 | JP Morgan | Overweight |
| 2021-10-15 | 재개 | Cowen | Outperform |
| 2021-03-03 | 다운그레이드 | Goldman | Buy → Neutral |
| 2020-10-08 | 재개 | BTIG Research | Buy |
| 2020-09-09 | 개시 | Morgan Stanley | Equal-Weight |
| 2020-06-03 | 개시 | Goldman | Buy |
| 2019-07-23 | 개시 | BTIG Research | Buy |
| 2019-07-22 | 개시 | BofA/Merrill | Buy |
| 2019-07-22 | 개시 | Cowen | Outperform |
| 2019-07-22 | 개시 | Goldman | Neutral |
| 2019-07-22 | 개시 | Guggenheim | Buy |
| 2019-07-22 | 개시 | William Blair | Outperform |
모두보기
Adaptive Biotechnologies Corp 주식(ADPT)의 최신 뉴스
Adaptive Biotechnologies COO Rubinstein sells $762k in ADPT stock - Investing.com
Adaptive Biotechnologies (ADPT) COO exercises options and sells 57,180 shares - Stock Titan
[144] Adaptive Biotechnologies Corp SEC Filing - Stock Titan
ADPT (NASDAQ: ADPT) lists 140,666 RSUs and 329,600 PSUs in Rule 144 filing - Stock Titan
Insider sales at Adaptive Biotechnologies (NASDAQ: ADPT) include 122,523 RSUs - Stock Titan
18,672 RSUs registered for sale by filer (ADPT) via Morgan Stanley - Stock Titan
Chad Robins lists multiple ADPT share sales in Form 144 (ADPT) - Stock Titan
Adaptive Biotechnologies (ADPT) Moves 5.8% Higher: Will This Strength Last? - Yahoo Finance
Adaptive Biotechnologies Corporation $ADPT Shares Sold by Braidwell LP - MarketBeat
Adaptive Biotechnologies CFO Piskel sells $245,910 in shares By Investing.com - Investing.com Nigeria
Insider Sell: Michelle Griffin Sells 15,394 Shares of Adaptive B - GuruFocus
Francis Lo Sells 30,593 Shares of Adaptive Biotechnologies (NASDAQ:ADPT) Stock - MarketBeat
Insider Selling: Adaptive Biotechnologies (NASDAQ:ADPT) CEO Sells 470,167 Shares of Stock - MarketBeat
Adaptive Biotechnologies’ president Rubinstein sells $2.37 million in ADPT stock - Investing.com
Adaptive Biotechnologies director Griffin sells $214,130 in stock - Investing.com
Adaptive Biotechnologies CCO Bobulsky sells $544k in ADPT stock By Investing.com - Investing.com Canada
Adaptive Biotechnologies CCO Bobulsky sells $544k in ADPT stock - Investing.com Australia
Adaptive Biotechnologies Executives Sell Shares to Cover Tax Obligations - TradingView
Adaptive Biotechnologies’ chief commercial officer sells $831k in stock By Investing.com - Investing.com Nigeria
Adaptive Biotechnologies CFO Piskel sells $245,910 in shares - Investing.com
Adaptive Biotechnologies’ chief people officer Lo sells $430k in stock - Investing.com Canada
Adaptive Biotechnologies’ chief people officer Lo sells $430k in stock By Investing.com - Investing.com South Africa
Adaptive Biotechnologies’ chief commercial officer sells $831k in stock - Investing.com
Adaptive Biotechnologies’ chief scientific officer sells $6.19 million in stock - Investing.com
Adaptive Biotechnologies CEO Robins sells $6.19 million in ADPT stock - Investing.com
Adaptive Biotechnologies Executives Sell Shares for Tax Obligations - TradingView
Adaptive Biotechnologies Hits Day Low of $12 Amid Price Pressure - Markets Mojo
Adaptive Biotechnologies (NASDAQ:ADPT) Shares Gap UpWhat's Next? - MarketBeat
Adaptive Biotechnologies (ADPT) CFO executes mandated 18,672-share sale for RSU tax withholding - Stock Titan
Adaptive Biotechnologies (NASDAQ:ADPT) Stock Price Down 9.9%Here's Why - MarketBeat
Francis Lo reports multiple 10b5-1 share sales for ADPT (NASDAQ: ADPT) - Stock Titan
Michelle Griffin sells 48,044 ADPT shares (ADPT) for $735K - Stock Titan
ADPT (Adaptive Biotechnologies) NonCurrent Deferred Revenue : $1.0 Mil (As of Dec. 2025) - GuruFocus
Piper Sandler reiterates Adeptus Biotechnologies stock rating at overweight By Investing.com - Investing.com India
Insider Selling: Adaptive Biotechnologies (NASDAQ:ADPT) COO Sells 19,460 Shares of Stock - MarketBeat
Adaptive Biotechnologies Executive Sells Over $1.2 Million in Company Stock - TradingView
Piper Sandler reiterates Adeptus Biotechnologies stock rating at overweight - Investing.com
[Form 4] Adaptive Biotechnologies Corp Insider Trading Activity - Stock Titan
Lo Francis, chief people officer at Adaptive Biotechnologies, sells $574k in ADPT By Investing.com - Investing.com South Africa
Lo Francis, chief people officer at Adaptive Biotechnologies, sells $574k in ADPT - Investing.com Nigeria
Adaptive Biotechnologies (ADPT) HR chief offloads shares to cover RSU taxes - Stock Titan
Adaptive Biotechnologies Exec Sells Shares to Cover Tax - TradingView
Do Insider Sales Align With Adaptive Biotechnologies' (ADPT) MRD-Driven Momentum and Long-Term Strategy? - simplywall.st
Adaptive Biotechnologies (NASDAQ:ADPT) Stock Rating Lowered by Wall Street Zen - MarketBeat
Director at Adaptive Biotechnologies (ADPT) receives 15,625-share award - Stock Titan
Adaptive Biotechnologies (NASDAQ: ADPT) grants 44,063 shares to Chief People Officer - Stock Titan
Adaptive Biotechnologies (ADPT) CFO receives 61,875-share stock grant - Stock Titan
Director Michelle Renee Griffin receives 15,625 ADPT shares in stock grant - Stock Titan
Loss Report: Will Adaptive Biotechnologies Corporation stock go up in YEAR - baoquankhu1.vn
Insider Sales Put Focus On Adaptive Biotechnologies Growth Story And Dilution Risk - Yahoo Finance
Adaptive Biotechnologies’ Rubinstein sells $1.49m in shares By Investing.com - Investing.com UK
Adaptive Biotechnologies Corp (ADPT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.42%
1.08%
자본화:
|
볼륨(24시간):